Volume 120, Issue 10, Supplement 2 , Page v, October 2007
Faculty Disclosures
Article Outline
The authors who contributed to this publication have disclosed the following industry relationships:
Amjad AlMahameed, MD, is a member of the Speakers’ Bureau for GlaxoSmithKline and sanofi-aventis; serves as a consultant to GlaxoSmithKline and sanofi-aventis; is an advisory board member for GlaxoSmithKline; has received research/grant support from GlaxoSmithKline and sanofi-aventis; and is the recipient of honoraria from GlaxoSmithKline and sanofi-aventis.
Teresa L. Carman, MD, has served as a member of the Speakers’ Bureau for Bristol-Myers Squibb and sanofi-aventis; and has served as a consultant to Bristol-Myers Squibb and sanofi-aventis.
Seth Clemens, MD, receives research/grant support from Kimberly-Clark; and honoraria from Kimberly-Clark
Mark A. Crowther, MD, MSc, has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
Andra H. James, MD, MPH, has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
Kenneth V. Leeper, Jr., MD, is a member of the Speaker’s Bureau for Ortho-McNeil and Pfizer Inc; serves as a consultant for Ortho-McNeil and Pfizer Inc; receives research/grant support from Kimbery-Clark; and receives honoraria from Kimberly Clark, Ortho-McNeil, and Pfizer Inc.
Andrew F Shorr, MD, MPH, is a member of the Speaker’s Bureau for GlaxoSmithKline and sanofi-aventis; serves as a consultant/advisory board member for GlaxoSmithKline and sanofi-aventis; and has received research/grant support from GlaxoSmithKline and sanofi aventis.
PII: S0002-9343(07)00917-5
doi:10.1016/j.amjmed.2007.09.007
Volume 120, Issue 10, Supplement 2 , Page v, October 2007

